Summary
Boston Scientific Corporation (BSX) has filed an 8-K report on July 29, 2026, to announce its financial results for the second quarter ended June 30, 2026. The primary driver of this filing is the accompanying press release (Exhibit 99.1), which contains the detailed financial performance for the period. Investors should refer to this press release for specific figures related to revenue, profitability, and any forward-looking guidance the company may have provided. While the 8-K itself does not contain the detailed financial data, it officially signals the release of this information to the market. The company has specified that the information in Item 2.02 and Exhibit 99.1 is furnished, not filed, which means it is not subject to the same liabilities under Section 18 of the Exchange Act. Nevertheless, this quarterly update is crucial for understanding the company's operational execution and financial health in the current reporting period.
Key Highlights
- 1Boston Scientific Corporation (BSX) announced its Q2 2026 financial results on July 29, 2026.
- 2The key financial details are provided in a press release furnished as Exhibit 99.1 to the 8-K filing.
- 3Investors should consult the press release for specific revenue, earnings, and operational performance metrics.
- 4The company has not incorporated these results into other filings under standard disclosure rules.
- 5This 8-K serves as the official notification of the Q2 2026 earnings release.
- 6No specific financial figures or forward-looking statements are detailed within the 8-K filing itself, only the announcement of their release.